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Abstract
Background: The transcriptomes of peripheral blood cells in children with juvenile idiopathic arthritis (JIA) have
distinct transcriptional aberrations that suggest impairment of transcriptional regulation. To gain a better
understanding of this phenomenon, we studied known JIA genetic risk loci, the majority of which are located
in non-coding regions, where transcription is regulated and coordinated on a genome-wide basis. We examined
human neutrophils and CD4 primary T cells to identify genes and functional elements located within those risk loci.
Methods: We analyzed RNA sequencing (RNA-Seq) data, H3K27ac and H3K4me1 chromatin immunoprecipitation-
sequencing (ChIP-Seq) data, and previously published chromatin interaction analysis by paired-end tag sequencing
(ChIA-PET) data to characterize the chromatin landscapes within the known JIA-associated risk loci.
Results: In both neutrophils and primary CD4+ T cells, the majority of the JIA-associated linkage disequilibrium (LD)
blocks contained H3K27ac and/or H3K4me1 marks. These LD blocks were also binding sites for a small group of
transcription factors, particularly in neutrophils. Furthermore, these regions showed abundant intronic and intergenic
transcription in neutrophils. In neutrophils, none of the genes that were differentially expressed between untreated
patients with JIA and healthy children were located within the JIA-risk LD blocks. In CD4+ T cells, multiple genes,
including HLA-DQA1, HLA-DQB2, TRAF1, and IRF1 were associated with the long-distance interacting regions within the
LD regions as determined from ChIA-PET data.
Conclusions: These findings suggest that genetic risk contributes to the aberrant transcriptional control observed in
JIA. Furthermore, these findings demonstrate the challenges of identifying the actual causal variants within
complex genomic/chromatin landscapes.
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Background
One of the significant findings to emerge from transla-
tional studies of polyarticular juvenile idiopathic arthritis
(JIA) has been the observation that peripheral blood
cells in children with this disease have distinctly abnormal
expression profiles. These abnormalities can be observed
in neutrophils [1], peripheral blood mononuclear cells
(PBMC) [2], and whole blood expression profiles [3], and
do not correct even when children achieve remission [4].
In neutrophils, the transcriptional abnormalities are linked
to perturbations in fundamental metabolic processes [5].
Furthermore, both hypervariable gene analyses [6] and
contingency analyses [5] suggest that these transcriptional
aberrations reflect impairment of the mechanisms through
which transcription is regulated and coordinated on a
genome-wide basis [7].
In addition to identifying transcriptional abnormalities,
there has also been considerable progress in our ability
to identify genetic risk in JIA [8, 9]. Furthermore, we are
beginning to understand the contribution that genetic
variance makes to the heterogeneity of clinical response
to first-line agents such as methotrextate [10]. However,
taking genetic risk information and integrating it into a
coherent, testable hypothesis of disease pathogenesis has
remained challenging. A recent genetic fine mapping
study by Hinks et al. [11] illustrates that challenge.
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While these authors were able to identify multiple pre-
viously unknown regions of genetic risk for JIA using
the Illumina Immunochip, the majority of the risk-
associated variants were located within non-coding
regions of the genome. In this regard, JIA resembles al-
most every other complex trait that has been studied
using genome-wide association studies (GWAS) [12, 13],
including immunologic/autoimmune diseases [14]. Thus,
although it is common to identify genetic risk loci in
terms of the closest protein-coding gene, we are
learning that the genome is far more complex than
previously imagined, and that the presence of a risk-
conferring single nucleotide polymorphism (SNP) near
a specific gene is not prima facie evidence that the
causal variants have anything to do with that particu-
lar gene [15].
We have previously demonstrated how the field might
begin to make sense of the wealth of genetic data that
are being generated by GWAS and fine mapping studies
[16], and how understanding genetic risk might provide
additional insight into the transcriptional abnormalities
seen in JIA. We recently demonstrated that the majority
of the disease-associated SNPs identified in a genetic fine
mapping study by Hinks et al. that are situated within
the non-coding genome are located within linkage dis-
equilibrium (LD) blocks that are enriched for H3K4me1/
H3K27ac histone marks, epigenetic signatures associated
with enhancer function, in both neutrophils and CD4+
T cells. Several of these same LD blocks contain non-
coding RNAs that were identified on RNA sequencing
(RNA-Seq) and verified by reverse transcriptase poly-
merase chain reaction (rtPCR) [16].
Our earlier paper focused entirely on the novel risk re-
gions identified in the Hinks study [11]. In the current
study, we examined additional regions of genetic risk as
recently reviewed by Hersh et al. [8] and Herlin et al.
[9]. We demonstrated how understanding the transcrip-
tome and functional, non-coding genome allows us to
better understand the nature of genetic risk in JIA and
the well-described transcriptional aberrations. In the
current paper, we examine the chromatin landscapes in
both CD4+ T cells and neutrophils. The former are
widely accepted as important mediators of the pathobi-
ology of JIA [17], and the latter have become the subject
of increasing interest from the standpoint of the role(s)
in childhood-onset rheumatic diseases [18]. We used
publically available genomic data and our own RNA-Seq
data to gain mechanistic insights into JIA disease pro-
cesses from genetic risk data.
Methods
Defining LD regions
SNPs used in this query are listed in Table 1 and were pre-
viously reviewed by Hersh et al. [8], Herlin et al. [9] and
Hinks et al. [11]. We used an SNP Annotation And Proxy
search (SNAP) database (http://www.broadinstitute.org/
mpg/snap) [19] to define LD blocks based on the location
of each SNP. In brief, we used the settings as follows: SNP
dataset: 1000 Genome pilot 1 and HapMap 3 (release 2),
r2 threshhold: 0.9, Population Panel: CEU, Distance limit:
500. We selected the smallest number as our start loca-
tion and the largest number as our stop location for
each defined LD block.
Analysis of neutrophil RNA-Seq data
We queried neutrophil RNA-seq data from previously
published RNA-seq studies [16, 20, 21] by uploading the
data into the University of California Santa Cruz (UCSC)
Genome Browser. The previously defined LD blocks
were queried and visually inspected for signal representing
intronic and intergenic transcripts as described in our pre-
vious paper [16]. We then selected two representative
transcripts (one intronic and one intergenic) to confirm
the presence of non-coding transcripts in these regions.
Verification of non-coding RNA transcripts identified in
neutrophils within the JIA-associated LD blocks
Complementary DNA was synthesized from total RNA
using an iScript cDNA Synthesis kit (Bio-Rad). rt-PCR
was performed using a HotStar Master PCR kit (Qiagen)
with a Veriti thermocycler (Life Technologies) and in-
cluded a control with no reverse transcription to exclude
the possibility of an artifactual result due to contaminating
genomic DNA. The temperature profile consisted of an
initial step of 95 °C for 10 minutes, followed by 35 cycles
of 95 °C for 30 seconds, 60 °C for 30 seconds and 72 °C for
30 seconds, and then a final step of 72 °C for 10 minutes.
PCR products were resolved in 1.5% agarose gel. The
nucleotide sequences of the primers were as follows: for
ncTNFa (chr6: 31,544,379-31,544,485), 5′-CCTAATTCTG
GGTTTGGGTTTGGG-3′ (forward) and 5′-CCTACTT
TCACCTCCATCCATCCT-3′ (reverse); for ncSTAT4
(chr2:191,915,516-191,915,617), 5′- GTCTTGTGCAACT
TCTTCCTTTC-3′ (forward) and 5′- ACCCTGTGACTG
TTTGAGATTAC-3′ (reverse).
ENCODE transcription factor binding site (TFBS)
enrichment
ENCODE TFBS data were downloaded from UCSC
Genome Browser ENCODE data (http://hgdownload.
cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeReg
TfbsClustered/). Only the TFBS information annotated
for blood cells was used. The whole genome was binned
to 100 bp bins and intersected with H3K4me1 or
H3K27ac peak regions, which were used as background.
Fisher’s exact test was applied to test the significance of
the enrichment of TFBS of each transcription factor
within H3K4me1 or H3K27ac peaks in LD blocks
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compared to other regions with H3K4me1 or H3K27ac
peaks across the whole genome. We set the cutoff of the
false discovery rate (FDR) to 0.05 for all the analyses.
Identification of H3K4me1/H327ac histone marks within
LD regions
We used H3K4me1/H3K27ac ChIP-Seq data previously
generated by our group from neutrophils of healthy adults
[16] as our reference source for H3K4me1/H3K27ac
genomic locations in neutrophils [GEO:GSE66896]. The
H3K4me1/H3K27ac ChIP-Seq data reported on the Road-
map Epigenomics collection were used as our reference
source for H3K4me1/H3K27ac genomic locations in CD4+
T cells [GEO:GSE198927]. The intersection of H3K4me1/
H3K27ac peaks within LD regions was obtained using the
bedtools intersect procedure [22] as described in our
previous paper [16].
Identifying chromatin interactions in CD4+ T cells within JIA
risk loci
Functional DNA elements such as enhancers do not
always regulate the nearest gene. Indeed, in a recent
study of chromatin conformation using HiC in T and B cell
lines, Martin et al. [15] showed that >80% of long distance
chromatin interactions occurred at distances >500 kb. We
therefore queried an existing chromatin interaction ana-
lysis by paired-end tag sequencing (ChIA-PET) dataset for
CD4+ T cells (GSE32677) [23] to determine chromatin in-
teractions within the JIA-associated risk loci. This dataset
used H3K4me2 as a marker for active enhancers, and thus
provides a means of estimating those genes/gene networks
that are regulated by specific enhancers or groups of en-
hancers. The chromosome coordinates for the observed
6520 long-distance chromatin interactions were converted
from hg18 to hg19 using UCSC Genome browser LiftOver
tool (http://www.genome.ucsc.edu/cgi-bin/hgLiftOver). For
these analyses, we queried all known JIA-associated risk
regions.
Identifying molecular pathways of disease-associated
SNPs
One means of using genetic risk data to provide mechanis-
tic insights is to identify specific biological pathways
encompassed by SNP-associated genes [24, 25]. However,
Table 1 Histone marks in the SNP LD blocks in neutrophils and CD4 + T cells
LD region SNP Neutrophils CD4 + T cells
H3K4me1 mark H3K27ac mark H3K4me1 mark H3K27ac mark
chr1: 206940310 - 206947167 rs1800896 Y N Y Y
chr1: 25197155 - 25203390 rs4648881 Y N Y N
chr11: 36336263 - 36371757 rs4755450, rs7127214 N N N N
chr12: 111884608 - 111932800 rs3184504 Y Y Y Y
chr12: 112486818 - 112906415 rs17696736 Y Y Y Y
chr13: 40299842 - 40368601 rs7993214, rs9532434 N N Y N
chr13: 43056036 - 43066523 rs34132030 N N N N
chr16: 11400900 - 11435990 rs66718203 Y Y Y N
chr18: 12821903 - 12880206 rs7234029 Y Y Y Y
chr2: 100806514 - 100837567 rs10194635, rs6740838, rs1160542 Y N Y Y
chr2: 191900449 - 191935804 rs3821236 Y Y Y Y
chr2: 191943742 - 191970120 rs7574865 N N Y N
chr22: 24234493 - 24237862 rs755622 Y Y Y Y
chr3: 119125202 - 119243934 rs4688013, rs4688011 Y Y Y Y
chr3: 46253650 - 46350716 rs79893749 Y Y Y Y
chr4: 123141054 - 123548068 rs17388568 Y Y Y Y
chr6: 112359543 - 112448654 rs2280153 Y Y Y Y
chr6: 137959235 - 138006504 rs6920220 N N Y N
chr6: 31492453 - 31543031 rs1800629 N Y Y Y
chr7: 22774437 - 22811384 rs6946509, rs7808122 N N N N
chr7: 28152193 - 28243473 rs10280937, rs73300638 Y Y Y Y
chr9: 123636121 - 123723351 rs10818488 Y Y Y Y
chr9: 123640500 - 123706382 rs2900180 Y Y Y Y
SNP single nucleotide polymorphism, LD linkage disequilibrium, chr chromosome, Y yes, N no
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there is a considerable breadth of opinion about what
constitutes an SNP-associated gene, as the actual causal
variants may be a considerable distance (in genomic terms)
from the risk-associated SNP. We therefore used the
method of Brodie et al. [26] to identify molecular pathways
encompassed by JIA-associated SNPs across broad genomic
distances. We queried regions 200 kb upstream and down-
stream of the JIA-associated SNPs, as outlined previously
[24] to define genes and pathways associated with JIA
risk SNPs.
Results
Our previous work had queried new SNPs recently iden-
tified in a genetic fine mapping study published by
Hinks et al. [4]. In the current study, we queried SNPs
that were identified in reviews by Hersh et al. [8] and
Herlin et al. [9] and those SNPs in Hinks et al. [11] that
have not been analyzed in previous work and have estab-
lished associations with JIA (Table 1). We used these
SNPs to generate LD blocks using the SNAP database
[19] and examined the functional genomic elements
within these defined regions. We included SNPs located
within non-coding regions of the genome (introns or
intergenic areas), i.e., the majority of the JIA-associated
SNPs.
Verification of non-coding transcripts within neutrophils
in JIA-associated LD blocks
Review of RNA-Seq data using the UCSC Genome
Browser suggested the presence of multiple non-coding
RNA transcripts in neutrophils within the JIA-associated
LD blocks. We used rtPCR to confirm the presence of
two of these transcripts, i.e., those within the LD blocks
containing the rs3821236 and rs1800629 SNPs. Figure 1
shows detectable expression of these transcripts in neu-
trophils from a healthy child and a patient with JIA. This
finding corroborates the idea that the additional JIA-
associated LD blocks queried in the current paper contain
functional, non-coding RNA transcripts, and corroborates
the findings from our earlier paper [16].
Location of H3K4me1/H3K27ac marks within LD blocks
For these analyses, we examined only those LD blocks
not previously examined in our earlier paper [16] as
noted in “Methods”. We identified LD blocks for all of
the 30 risk SNPs, which were located in a total of 23 LD
blocks. For those 23 LD blocks, we examined whether
there are functional elements located in neutrophils or
CD4+ T cells within these risk-conferring regions.
Our first analyses were in neutrophils. Of the 23 risk
loci, 16 LD blocks contained H3K4me1 marks, while 14
Fig. 1 University of California Santa Cruz (UCSC) Genome Browser screen shot showing abundant intronic transcription in the TNF gene (a) and in
the STAT4 gene (b) within introns. Black bars indicate the region amplified by PCR experiments, as described in “Methods.” c, d Agarose gel images
showing qualitative PCR amplification of intronic transcription (ncRNA) in the TNF gene (c) and in the STAT4 gene (d) in neutrophils. N neutrophil RNA
not subjected to reverse transcription, R neutrophil RNA subjected to reverse transcription prior to amplification. Neutrophils were isolated from
patients with juvenile idiopathic arthritis (JIA) and healthy children (HC). Absence of signal in PCR amplifications that were performed without prior
reverse transcription indicates that the signal was not being produced by contaminating DNA
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LD blocks contained H3K27ac marks; 13 LD blocks con-
tained both H3K4me1 and H3K27ac marks (Table 1). In
all, 17 out of the 23 LD blocks contained either H3K4me1
or H3K27ac marks. The H3K4me1 and H3K27ac marks
were significantly enriched in these LD block regions
compared with non-LD block regions as determined by
Fisher’s exact test (p value <2.2e-16 for both H3K4me1
and H3K27ac marks).
Representative screen shots from the UCSC genome
browser within two of the LD regions of interest are
shown in Fig. 2. The LD block containing rs755622, for
example (Fig. 2a), includes the promoter for the macro-
phage inhibitory factor (MIF) gene, but this region is
also rich in transcription factor (TF) binding regions and
contains H3K4me1/H3K27ac histone marks. Elevated
MIF has been identified in patients with all three major
JIA subtypes [27], although MIF is most elevated in chil-
dren with the oligoarticular and systemic forms of the
disease. Similarly, the neutrophil chromatin landscape
around rs2900180 (Fig. 2b) has considerable genomic
complexity. There is an expressed gene within this region,
i.e., the TNF receptor-associated factor 1 (TRFA1)); there
has been strong interest in the TNF signaling pathways
since the efficacy of anti-TNF therapies was demonstrated
in children with JIA [28]. At the same time, this region
contains both H3K4me1/H3K27 marked enhancers and
abundant TF binding not isolated to the TRAF promoter.
Similarly, Additional file 1: Figure S1 shows multiple
functional elements adjacent to potentially disease-relevant
genes such as PTPN2 (Additional file 1: Figure S1A) and
NFkB inhibitor-like protein 1 (NFkBIL1, Additional file 1:
Figure S1B). Thus, these findings corroborate our previous
report [9] on the genetic risk regions identified in the Hinks
paper [11], i.e., the genetic risk largely encompasses regions
of the genome rich in functional elements that serve to
regulate and coordinate transcription on a genome-wide
basis.
We next examined H3K4me1/H3K27ac marked regions
in CD4+ T cells in those same 23 LD blocks. We queried
whether there are functional elements located in CD4+ T
cells within these risk-conferring regions. Of the 23 LD
blocks, 20 contained H3K4me1 marks and 15 contained
H3K27ac marks. All of the 15 LD blocks that contained
H3K27ac marks also contained H3K4me1 marks (Table 1).
Thus, 20 out of 23 of the LD blocks contained either
H3K27ac or H3K4me1 marks in CD4+ T cells. The
H3K27ac and H3K4me1 marks are significantly enriched
in these LD block regions compared with non-LD block re-
gions as determined by Fisher’s exact test (p value <2.2e-16
for both H3K27ac and H3K4me1 marks).
Transcription factor enrichment within the LD blocks
While H3K4me1/H3K27ac marks themselves do not
unambiguously identify functional enhancers [29], the
appearance of TFBS within H3K4me1/H3K27ac-marked
regions is strong supportive evidence that these regions
are functional [30]. Therefore, for each of the 38 LD
blocks containing the 51 JIA-associated risk SNPs, we
queried whether there was significant enrichment for TF
binding in the H3K27ac/H3K4me1 marked regions. In
these analyses, we included genetic risk information from
the Hinks, Hersh, and Herlin papers. Thus, to determine
whether there was additional evidence that the H3K4me1/
H3K27ac marked regions within the JIA-associated LD
blocks had functional significance, we queried whether
there were significantly enriched TFBS within those loci
compared to other genomic regions that have H3K4me1/
H3K27ac marks.
For neutrophils, we observed highly enriched TF binding
in promoter regions (defined as (-5 K, 1 K) of TSS) within
these LD blocks. TFs that were particularly enriched in-
cluded POLR2A, CHD1 and TAF1 (Fig. 3a). We noted that
RUNX3 binding was also enriched within the H3K27ac-
marked regions (Fig. 3a), an interesting finding in that the
RUNX3 locus itself is associated with risk of JIA. This locus
is characterized, in neutrophils, by dense intergenic TF
binding, the presence of both H3K4me1 and H3K27ac
peaks overlapping with the TF binding regions, and both
intronic and intergenic RNA transcripts (not yet verified
by rtPCR experiments; see Additional file 2: Figure S3).
These findings suggest complex relationships between en-
hancers and promoters, and perhaps non-coding RNA
transcripts, leading to complex levels of gene regulation in
neutrophils in health and in disease states such as JIA.
For CD4+ T cells, we observed a limited number of
TFBS that were significantly enriched in the LD blocks
conferring risk of JIA that co-localized with H3K27ac/
H3K4me1 histone marks (Fig. 3b). These regions were
seen almost exclusively in promoters, defined as -5 K -1 K
of the transcription start site (TSS). These transcription
factors included POLR2A and GTF2F1. The majority of
the distal (non-promoter) regions within these LD blocks
were relatively depleted of TFBS. Thus, the LD blocks
with H3K27ac/H3K4me1 marks are not highly enriched
with TFs. This finding contrasts with what we observed in
neutrophils, as noted above, where there is significant
enrichment of TF binding within H3K4me1/H3K27ac-
marked regions.
Chromatin interactions in JIA risk loci
We used the 6520 long-distance chromatin interactions
from a previously-reported ChIA-PET data analysis of
CD4+ T cells [23] to define chromatin interactions in all
the JIA-associated LD blocks. We identified 11 LD blocks
that contained 48 long-range interactions. We noted that
all six of the interaction regions within the LD block
containing the SNP, rs10818488, are identical to the re-
gions within the LD block of rs2900180. Thus, 42 unique
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Fig. 2 (See legend on next page.)
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long-range interactions remained, 11 of which displayed
more than one interaction within or intersected with the
same LD blocks (Additional file 3: Table S1). For these
42 long-range interactions, 20 were promoter-promoter
(defined as (-5 K, 1 K) of TSS) interactions, 21 were
promoter-distal (non-promoter) interactions, and one
was a distal-distal interaction.
We next analyzed the ChIA-PET data in light of tran-
scriptomes from CD4+ T cells derived from healthy chil-
dren. We identified several genes within the CHIA-PET
interacting regions, including ILB, DDX39B, RASSF5
and JAK1, which demonstrated high levels of expression
(average fragments per kilobase of transcript (FPKM)
>100). We noted that there are multiple small RNA
molecules (snoRNA, miRNA, misc_RNA, snRNA) that
are encoded within these regions, but the sequencing
libraries were not prepared to detect their presence be-
cause the FPKM of those molecules is zero.
Among the 42 long-range interactions, 66 regions con-
tained both H3K4me1 and H3K27ac marks, while 2 re-
gions contained only H3K27ac marks and 11 contained
only H3K4me1 marks; only 5 of the interacting regions
contained neither H3K4me1 nor H3K27ac marks. There
were in all 61 genes associated with these long-range
interacting regions. The genes associated with regions
containing both H3K4me1 and H3K27ac marks have
average higher FPKM than those genes that contained
only H3K4me1 marks or those with no histone marks
(Additional file 4: Figure S2).
The ChIA-PET data point to complex layers of inter-
action and gene regulation within the JIA-associated risk
loci. Note, for example, there are multiple points of
interaction between the IRF1 and Corf56 genes, a locus
that also encodes a Y-RNA species. These genes are
physically adjacent to one another on chromosome 5, as
shown in Fig. 4a. This region is dense with functional
elements, including an H3K4me1/H3K27ac-marked en-
hancer, dense transcription factor binding, and multiple
DNase1 hypersensitivity sites. It is interesting to note
that our previous work from whole blood expression
profiles of untreated patients with JIA suggested an
important role for IRF1 networks in the pathogenesis of
JIA [3]. Equally interesting is the physical interaction
detected between the HLADQB1 and HLADQB2 loci.
Association between JIA risk and class II HLA alleles
has been long recognized, although the alleles at the
DRB1 locus are thought to have stronger effects than
those at the DQB1 or DQB2 loci [31]. The genome
browser shot in Fig. 4b demonstrates the complexity of
this locus. Complex interactions between TRAF1 and
multiple adjacent genes (C5, PHF19, and CNTRL), and
TRAF1 intragenic interactions were also observed on
the ChIA-PET data by Chepelev et al. [23].
Enriched molecular pathways of disease-associated SNPs
We used the method of Brodie et al. [24] and the
PANTHER database [32] to identify significantly enriched
biological processes and pathways for the 246 protein-
coding genes and processed transcripts associated with
the 51 JIA risk SNPs. Using a cutoff of a Bonferroni-
adjusted p value <0.05, the enriched PANTHER pathways
are related to interleukin signaling and inflammation me-
diated by chemokine and cytokine signaling. The enriched
biological processes involve antigen processing and pres-
entation, cellular defense response and other immuno-
logically relevant processes (Additional file 5: Table S2).
Discussion
In this paper, we mined existing datasets in order to gain
a better understanding of the nature of genetic risk in
JIA and therefore gain a better understanding of the
transcriptional abnormalities that we and others have
previously observed in untreated patients. We found that
most of the JIA-associated SNPs lie within the non-coding
genome, in regions that are dense with TF binding sites,
DNaseI hypersensitive sites, epigenetic signatures of en-
hancer function, and, in the case of neutrophils, non-
coding RNA transcripts. These findings strongly support
the idea that genetic risk in JIA is determined by aberrant
regulation of gene expression rather than the improper
function of proteins mediated by an improper amino acid
substitution. This idea is now gaining broad acceptance in
the field of autoimmunity [33], and may provide the basis
for understanding the transcriptional abnormalities seen
in a broad spectrum of peripheral blood cells in JIA. These
findings also demonstrate the importance of considering
(See figure on previous page.)
Fig. 2 Representative screen shots from the University of California Santa Cruz Genome Browser show functional elements within neutrophil
genomes. Black horizontal bar (top) represents the linkage disequilibrium (LD) blocks of the corresponding genome-wide association study single
nucleotide polymorphism (SNP). Black horizontal bars between individual tracks represent H3K27ac and H3K4me1 peak regions generated from
chromatin immunoprecipitation-sequencing (ChIP-Seq) data. Gray bars at the bottom of each image represent the transcription factor ChIP-seq of
161 factors from ENCODE with factorbook motifs. a LD block of rs755622 in neutrophils. Note there are expressed genes within this LD block, and
the LD block contains H3K27ac and H3K4me1 regions with multiple potential transcription factor binding site (TFBS) within those regions. b LD block
of rs2900180 in neutrophils. Note that there is one gene, the tumor necrosis factor receptor-associated factor (TRAF1), which is expressed within this
LD block. This LD block also contains both H3K27ac and H3K4me1 peak regions with multiple TFBS within those regions. Potential active enhancers
(region containing both H3K27ac and H3K4me1 peak regions) are highlighted in red. MIF macrophage inhibitory factor
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the chromatin context around disease-associated SNPs,
which may have no functional association at all with the
“nearest gene.”
At the completion of the Human Genome Project,
there was some surprise and even a little dismay at how
little of the genome contains protein-encoding genes.
Fig. 3 Enrichment of transcription factors (TFs) in H3K4me1/H3K27ac mark regions. Heatmap of significantly enriched TFs with their transcription
factor binding sites (TFBS) in H3K27ac or H3K4me1 peak regions in neutrophil cells (a) and CD4 + T cells (b), considering promoter and distal
regions separately. TFs are ranked according to false discovery rate (FDR) (the lowest FDR with the highest rank) and normalized to (0,1) by
dividing the absolute highest rank value for enrichment (red) and depletion (blue) separately. (normalized rank >0 = enrichment, <0 = depletion)
Zhu et al. Arthritis Research & Therapy  (2017) 19:57 Page 8 of 12
When the entire project was completed, only approxi-
mately 2% of the DNA was found to encode proteins [34].
One of the transformative findings from the ENCODE and
Roadmap Epigenomics projects has been the discovery of
the richness of the non-coding genome. Enhancers, insula-
tors, CCCTC binding factor (CTCF) binding sites (which
regulate chromatin conformation), etc., are broadly distrib-
uted throughout the genome and demonstrate that the
processes of regulating gene expression and coordinating
expression on a genome-wide basis is extraordinarily com-
plex [35]. The field of immunology is now making
considerable progress in identifying these functional ele-
ments and how they regulate transcription and therefore
immune responses [36].
The findings from ENCODE and Roadmap Epige-
nomics, and the work we describe here, demonstrate
Fig. 4 a Genome browser shot of the interferon regulatory factor 1 (IRF1)/C5orf56 locus in CD4 primary T cells, which is an epigenetically rich
region showing dense transcription factor binding, multiple DNase1 hypersensitivity sites, and active enhancers with both H3K27ac and H3K4me1
marks. b TNF receptor-associated factor 1 (TRAF1) locus with rich epigenetic architecture in this locus, including multiple transcription factor binding
sites, DNase1 hypersensitive sites, and active enhancers (H3K27ac and H3K4me1 marked regions). CNTRL control, HC healthy children
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that identifying specific causal variants in JIA is going to
be an ongoing challenge. A primary reason for this is the
complexity of the risk loci. While many of these loci en-
compass genes that are of strong immunologic interest
(e.g., MIF, TRAF1, PTNP2, NFkBIL1), these same loci
are also rich in other functional elements that regulate
transcription on a global basis. For example, Fig. 2a is a
simplified genome browser screen shot that shows the
neutrophil chromatin landscape around rs755622. While
the actual SNP is within the promoter of the MIF gene,
the entire LD block contains both H3K4me1 and
H3K27ac histone marks (strong evidence for an active
enhancer in this region) and rich TF binding that is not
localized exclusively to the promoter. Similar genomic
features can also be seen in this region in CD4+ T cells
(data not shown).
We also found a large degree of complexity around
rs2900180 (Fig. 2b), and rs2847293/rs7234029, which are
in the same LD block. The region containing rs2847293/
rs7234029 is of broad general interest to the field of
immunology, as this LD block includes the PTPN2 gene.
While PTPN2 is generally considered a regulator of T
cell responses, this protein tyrosine phosphatase is broadly
expressed in innate immune cells, including in neutro-
phils, where it serves as a negative regulator of cytokine
signaling [37]. However, the PTPN2 locus is also charac-
terized by H3K4me1/H3K27ac-marked enhancers in neu-
trophils and CD4+ T cells, and an apparent non-coding
RNA molecule in the intron between the first and second
exons in neutrophils (Additional file 1: Figure S1A). Thus,
while it is tempting to focus on the protein-encoding
genes within these regions as the location of the causal
variants that lead to perturbed immune function, our data
invite other interpretations. Enhancers, for example, may
function at considerable distances (in genomic terms)
from the genes they regulate, and often do not regulate
the closest gene [38, 39]. This idea is shown in the recent
work of Martin et al. [15]. Using Hi-C chromatin con-
formation capture, these authors demonstrated that >80%
of long-distance chromatin interactions within T and B
cell lines occurred at distances >500 Mb. Thus, until there
is more solid experimental evidence to indicate otherwise,
we must be open to the possibility that it is the enhancer
function of these regions and/or the function of the
ncRNA that are perturbed by genetic variance rather than
specific functions or regulation of the nearby proteins.
This idea is corroborated by our analysis of the pub-
lished CD4+ T cells ChIA-PET dataset. ChIA-PET uses
crosslinked DNA to identify physical interactions between
regions of DNA, which may either be in close proximity
or many Mb apart on a specific chromosome (or even
regions that are on different chromosomes) [23, 40]. The
dataset we queried used H3K4me2 as a general mark for
active enhancers. We found that the JIA-associated
genetic risk loci display abundant and complex physical
interactions with (usually) nearby genomic elements.
The region encoding the TRAF1 gene is emblematic of
this complexity. We detected interactions between an
H3K4me2-marked region adjacent to the TRAF1 gene
and at least three other genes. These genes included
C5, the 5th component of the complement cascade, an
important inflammatory mediator. The region also in-
teracts with PHF19, which is itself a regulator of gene
expression. PHF19 is a member of the polycomb repres-
sive complex-2 (PRC-2) that is involved in gene silencing
[41]. The significance of the interaction between the
TRAF1 region and CNTRL (formerly for as CEP110), a
centrosomic protein [42] is not immediately clear.
ENCODE also revealed that much of the genome is
transcribed, and that many (if not most) of these non-
coding RNA species are functional. In rheumatology,
miRNA are the best-known of these non-coding RNA
families, as numerous papers have shown links between
specific miRNA molecules and specific immunologic
features of the rheumatic diseases (e.g., [43]). Our own
work has recently shown extensive re-wiring of mRNA-
miRNA networks within JIA neutrophils [44]. However,
the non-coding RNA world is broad, and includes RNA
species that regulate chromatin accessibility [45], per-
form enhancer functions [46–48], and encode for small
peptides [49]. Our current work also demonstrates the
presence of at least two intronic, non-coding RNA mole-
cules in the JIA-associated genetic risk loci. Such tran-
scripts are abundant in neutrophils [50] and may
regulate the decay of otherwise unstable mRNA tran-
scripts [47]. The specific roles of these transcripts in
neutrophil biology and/or the pathogenesis of JIA re-
main to be clarified. Their presence, however, serves to
demonstrate that the localization of a disease-associated
polymorphism within a specific gene does not necessarily
mean that genetic risk is conferred by alterations in the
protein-coding function of that gene.
The findings we report here provide an explanation for
an observation that we have recently reported: differen-
tially expressed genes in JIA are not situated within the
LD blocks that confer genetic risk [3]. Using whole blood
gene expression data from subjects of a National Institutes
of Health-funded clinical trial, corroborated by an inde-
pendent patient cohort, we reported that among >150
genes that were differentially expressed in patients and
healthy controls, none were encoded within the LD blocks
associated with JIA risk. Thus, the mechanisms through
which genetic variance leads to perturbed gene expression
are likely to be more complex than was previously con-
sidered. While it is possible that a different result might
be obtained using RNA-Seq data from purified cell
populations, the large number of gene-regulatory ele-
ments in the risk loci also invites us to consider that
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much of the genetic risk may be mediated by perturb-
ation of long-range interactions, as suggested by the
data reported by Martin et al. [15].
This paper adds to the mounting evidence that suggests
that the field of pediatric rheumatology may require a fun-
damental re-assessment of theories on the pathogenesis of
JIA. Long accepted as an “autoimmune disease” triggered
by the recognition of a “self” peptide by the adaptive
immune system, new evidence from the fields of genetics
and genomics ought to prompt a reconsideration of this
view. We propose, instead, that JIA emerges because of
genetic and epigenetically mediated alterations in leukocyte
genomes. These alterations, we propose, involve both in-
nate and adaptive immune systems and lead to expression
of inflammatory mediators in the absence of the external
signals normally required to initiate or sustain an inflam-
matory response. Our work in both whole blood buffy coats
[6] and neutrophils [5] is consistent with that interpretation
of the available gene expression and genetic data.
Conclusions
We demonstrated that the known genetic risk loci for
JIA are enriched for multiple functional elements within
the non-coding genome of human neutrophils. These func-
tional elements include rich TF binding sites, H3K4me1
and H3K27ac-marked enhancers, and non-coding RNAs.
We believe that these data and newer understanding of
genetic risk and genome function invite new understanding
of JIA pathogenesis, and may provide the basis for radical
new approaches to therapy.
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